| CARVIEW |
Understand complex
biology through agentic AI
Countless interactions across cells, tissues, and networks generate huge complexity. Untangling this complexity is beyond the limits of human intelligence alone.
Owkin is pioneering advanced agentic AI that can process vast biological data, uncover hidden causal relationships, and generate new actionable insights.
We generate and access rich multimodal patient data and biological samples across diverse populations from top academic research institutions.
K PRO is an agentic AI platform driving insight generation and decision making across teams to accelerate breakthroughs and advance drug discovery, development, and diagnostics.
Countless interactions across cells, tissues, and networks generate huge complexity. Untangling this complexity is beyond the limits of human intelligence alone.
Owkin is pioneering advanced agentic AI that can process vast biological data, uncover hidden causal relationships, and generate new actionable insights.
We generate and access rich multimodal patient data and biological samples across diverse populations from top academic research institutions.
K PRO is an agentic AI platform driving insight generation and decision making across teams to accelerate breakthroughs and advance drug discovery, development, and diagnostics.
One company: many breakthroughs
The technology foundation of our ecosystem is Owkin K. It is our cutting edge software that incorporates high quality multimodal data and AI tools to power breakthroughs across our companies.
Developer of OKN4395, a first-in-class selective triple inhibitor of EP2, EP4, and DP1. Currently in phase 1 (INVOKE), it is the first Owkin program to fully leverage AI, from asset selection to clinical development.
A leader in clinically validated digital pathology AI diagnostics. Solutions to support pathologists, screen biomarkers, and predict patient outcomes. The product portfolio spans tools for clinical trials, and regulatory-approved IVD solutions for routine clinical use.
Incubated by Owkin
Bioptimus is building the first universal reference AI foundation model in biology to drive advancements in scientific research and biotechnological innovation.
What makes our technology different?
Our AI is differentiated by top quality patient data, quantification technologies and cutting edge agentic applications:
What's new at Owkin?
We are hiring
Join our team
We are a community of diverse people bringing our energy and skills to find the right treatment for every patient.